Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9217
Full metadata record
DC FieldValueLanguage
dc.contributor.authorL. Diaz, Bruno-
dc.contributor.authorBandeira-Melo, Christianne-
dc.date.accessioned2024-12-18T03:09:51Z-
dc.date.available2024-12-18T03:09:51Z-
dc.date.issued2024-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/9217-
dc.description.abstractProstaglandin (PG)D2 is produced and/or triggered by different parasites to modulate the course of the infection. These findings position PGD2 as a therapeutic target and suggest potential beneficial effects of repositioned drugs that target its synthesis or receptor engagement. However, recent in vivo data may suggest a more nuanced role and warrants further investigation of the role of PGD2 during the full course and complexity of parasitic infectionsen_US
dc.titleParasitic infections: A new frontier for PGD2 functionsen_US
dc.typeArticleen_US
Appears in Collections:VOL 5 2024

Files in This Item:
File Description SizeFormat 
100077.pdf8.36 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.